Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
A Aissaoui
Observed name:
A. Aissaoui
Institution:
Sanofi (France)
Observed institution:
Sanofi (France)
ORCID:
0009-0001-3164-0292
Observed ORCID:
0009-0001-3164-0292
OpenAlex ID:
A5034106040
EE134 Pharmacoeconomic Evaluation of National Immunization Program Realisation in Algeria
2023
·
A. Laichour
, M. Kihel
, et al.
·
Value in Health
·
1
PDF
EE339 Budget Impact Analysis of Insulin Glargine-300U/Ml (GLA-300) for Treatment of T1DM and T2DM in Algerian Setting
2022
·
S Azzoug
, P Levy
, et al.
·
Value in Health
·
1
PDF
EE346 Comparative Cost and Saving Analysis of Insulin Glargine-300U/mL (Gla-300) vs Insulin Degludec 100 U/mL in the Treatment of Type 2 Diabetes Mellitus Based on the BRIGHT Study
2024
·
M Safia
, Z Hachelaf
, et al.
·
Value in Health
PDF
EE514 Budget Impact Model for Insulin Glargine-300U/mL (Gla-300) vs Insulin Degludec 100 U/mL in the Treatment of Type 1 Diabetes Mellitus Based on the Inrange Study
2024
·
M Safia
, Z Hachelaf
, et al.
·
Value in Health
PDF
EE1 "Unveiling the Hidden Costs of Flu in Algeria: A Micro-Costing Study on the Payor and Societal Burden of Seasonal Influenza"
2024
·
A Laichour
, J. Bartelt-Hofer
, et al.
·
Value in Health
EE681 Healthcare Resource Utilization for Children Under 15 Years Old With Type 1 Diabetics : A Retrospective, Multicenter Analysis
2024
·
A Boudis
, H Alioua
, et al.
·
Value in Health
EE631 Cost Minimization Analysis of the Switch to a New Immunization Schedule With a Hexavalent (DTAP-HBV-HIB-IPV) Vaccine in Algeria
2022
·
A Laichour
, A Aissaoui
, et al.
·
Value in Health
PDF
HPR145 Factors of Access to the Market of Innovative Specialties in Algeria: The Case of Hospital Drugs
2022
·
R Djafri
, S Djemai
, et al.
·
Value in Health
EE476 Budget Impact Analysis of iGlarLixi for Treatment of T2DM in Algerian Setting
2022
·
S Mimouni
, R Malek
, et al.
·
Value in Health
EE475 Observational, Retrospective Study on the Evaluation of Direct and Indirect Costs Generated by Multiple Myeloma (MM) in Algeria
2022
·
MA Bekadja
, C Ghezlane
, et al.
·
Value in Health
EE67 Cost Per Responder and Number Needed to Treat of iGlarlixi vs Premix BIAsp 30 in Algerian Setting
2022
·
R Malek
, S Mimouni
, et al.
·
Value in Health
Show more works
View as search
Works count:
11
Citation count:
2
H-index:
1
I10-index:
Year
Topic
Type
